The total return over the past 12 months is +107.84% vs. +16.94% for the S&P 500. So far it's up +36.68% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +107.84% | +97.37% | (18.99%) | (27.99%) | N/A | N/A |
| Total Return CAGR | +107.84% | +97.37% | (18.99%) | (27.99%) | N/A | N/A |
| Revenue CAGR | +6.88% | +62.47% | +37.66% | +84.01% | +49.92% | N/A |
| Net Income CAGR | +260.96% | N/A | (7.75%) | +96.17% | N/A | N/A |
| EPS CAGR | +174.66% | N/A | (14.73%) | +75.29% | +34.53% | N/A |
| Free Cash Flow CAGR | +229.38% | N/A | N/A | +136.45% | N/A | N/A |
| Operating Cash Flow CAGR | +228.71% | N/A | +56.24% | +136.69% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Nutex Health, Inc. (NUTX)
| Year | Start price | End price | NUTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $164.62 | $225.00 | +36.68% | +14.51% | +22.17% |
| 2025 | $31.69 | $164.62 | +419.47% | +17.72% | +401.75% |
| 2024 | $27.00 | $31.69 | +17.37% | +24.89% | (7.52%) |
| 2023 | $285.00 | $27.00 | (90.53%) | +26.19% | (116.72%) |
| 2022 | $618.00 | $285.00 | (53.88%) | (18.17%) | (35.71%) |
| 2021 | $202.50 | $618.00 | +205.19% | +28.74% | +176.45% |
| 2020 | $300.00 | $202.50 | (32.50%) | +18.37% | (50.87%) |
| 2019 | $375.00 | $300.00 | (20.00%) | +31.22% | (51.22%) |
| 2018 | $3,750.00 | $375.00 | (90.00%) | (4.56%) | (85.44%) |
| 2017 | $5,250.00 | $3,750.00 | (28.57%) | +21.70% | (50.27%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
